Response to "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?"
| dc.contributor.author | Luk, C. | |
| dc.contributor.author | Parsons, Richard | |
| dc.contributor.author | Lee, Ya Ping | |
| dc.contributor.author | Hughes, Jeff | |
| dc.date.accessioned | 2017-01-30T13:33:18Z | |
| dc.date.available | 2017-01-30T13:33:18Z | |
| dc.date.created | 2015-10-29T04:08:53Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Luk, C. and Parsons, R. and Lee, Y. and Hughes, J. 2014. Response to "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?" (Luk, C. and Parsons, R. and Lee, Y. and Hughes, J. 2014. Response to "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?" (2013; vol. 47, 6: pp. 773-780). Annals of Pharmacotherapy. 48 (3): pp. 432-432. Annals of Pharmacotherapy. 48 (3): pp. 432-432. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/32836 | |
| dc.identifier.doi | 10.1177/1060028013512832 | |
| dc.title | Response to "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?" | |
| dc.type | Journal Article | |
| dcterms.source.volume | 48 | |
| dcterms.source.number | 3 | |
| dcterms.source.startPage | 432 | |
| dcterms.source.endPage | 432 | |
| dcterms.source.issn | 1060-0280 | |
| dcterms.source.title | Annals of Pharmacotherapy | |
| curtin.department | School of Pharmacy | |
| curtin.accessStatus | Fulltext not available |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||